Back to results
US 11,376,263 B2Granted
Cyproterone acetate compositions and uses thereof
AssigneeFortress Biotech, Inc.
InventorsLindsay Rosenwald, Lei Zheng, Lucy Lu
Life of this patent
Estimating the term…
Abstract
Provided herein are oral drug preparations including cyproterone acetate and ethinylestradiol, dosing regimen for the drug preparations, and methods of treating diseases. The methods provided include the administration of the oral drug preparation to treat one or more symptoms of hyperandrogenic conditions or hyperandrogenic activities, to provide contraception, and to reduce a risk of vascular thromboembolism (VTE) in a subject.
Claims30
An oral drug preparation comprising:
- (a) a first composition comprising about 5 to 50 μg ethinylestradiol (EE) and about 1 to 10 mg cyproterone acetate (CPA);
- and
- (b) a second composition consisting essentially of about 1 to 10 mg CPA, wherein, beginning on day 15 of a dosing schedule, the second composition is administered on day 15 and then every other day.
An oral drug preparation comprising:
- (a) a first composition comprising about 5 to 50 μg ethinylestradiol (EE) and about 1 to 10 mg cyproterone acetate (CPA);
- and
- (b) a second composition consisting essentially of about 1 to 10 mg CPA, wherein beginning on day 8 of a dosing schedule, the second composition is administered on day 8 and then every other day.
An oral drug preparation comprising:
- a) a first composition comprising about 5 to 50 μg ethinylestradiol (EE) and about 1 to 10 mg cyproterone acetate (CPA);
- and
- b) a second composition comprising about 5 to 50 μg ethinylestradiol (EE) and about 1 to 10 mg cyproterone acetate (CPA);
- wherein the second composition comprises a lower amount of EE as compared to the first composition, and
- wherein the first and second compositions are administered to a subject on alternating days on a 30-day dosing schedule.
2 more elements
Dependencies are inferred from the claim text.